PIAS2

protein inhibitor of activated STAT 2, the group of Zinc fingers MIZ-type

Basic information

Region (hg38): 18:46803218-46920160

Links

ENSG00000078043NCBI:9063OMIM:603567HGNC:17311Uniprot:O75928AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PIAS2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PIAS2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
31
clinvar
1
clinvar
32
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 31 0 2

Variants in PIAS2

This is a list of pathogenic ClinVar variants found in the PIAS2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
18-46812438-C-T not specified Uncertain significance (Jun 28, 2022)2394687
18-46812474-T-C not specified Uncertain significance (Dec 21, 2023)3212558
18-46812480-T-C Benign (Oct 23, 2018)770451
18-46812493-A-T not specified Uncertain significance (Jan 22, 2024)3212557
18-46812532-A-T not specified Uncertain significance (Apr 09, 2024)3306375
18-46812548-G-A not specified Uncertain significance (Nov 27, 2024)3418117
18-46812564-T-C not specified Uncertain significance (Dec 10, 2024)3418118
18-46812590-T-C not specified Uncertain significance (Dec 28, 2023)3212556
18-46820951-T-C not specified Uncertain significance (Apr 07, 2023)2535243
18-46820986-T-C not specified Uncertain significance (Jan 29, 2025)3888617
18-46821008-T-C not specified Uncertain significance (Apr 26, 2023)2541324
18-46821008-T-G not specified Uncertain significance (Jan 23, 2024)3212555
18-46821017-G-T not specified Uncertain significance (Mar 02, 2023)2493585
18-46821063-C-T not specified Uncertain significance (Jun 30, 2022)3212554
18-46828046-A-G not specified Uncertain significance (Jul 27, 2022)2303856
18-46828122-C-T not specified Uncertain significance (Sep 22, 2022)2409149
18-46829757-C-G not specified Uncertain significance (Nov 10, 2024)3418116
18-46836358-C-T not specified Uncertain significance (Dec 16, 2022)2336182
18-46844764-T-C not specified Uncertain significance (Aug 12, 2021)2244345
18-46846783-T-C not specified Uncertain significance (Mar 28, 2024)3306374
18-46855381-T-C Benign (Mar 29, 2018)789494
18-46864208-A-C not specified Uncertain significance (May 30, 2023)2529682
18-46890619-A-G not specified Uncertain significance (Jul 25, 2023)2613505
18-46890628-G-T not specified Uncertain significance (Sep 22, 2022)2312818
18-46890630-T-C not specified Uncertain significance (Dec 27, 2022)2339730

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PIAS2protein_codingprotein_codingENST00000585916 14111771
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9970.00282125740061257460.0000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.062263310.6820.00001684045
Missense in Polyphen1638.2640.41815488
Synonymous0.9471071200.8900.000006371212
Loss of Function4.61330.50.09840.00000164392

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001520.000152
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000008840.00000879
Middle Eastern0.000.00
South Asian0.00006550.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor. Plays a crucial role as a transcriptional coregulator in various cellular pathways, including the STAT pathway, the p53 pathway and the steroid hormone signaling pathway. The effects of this transcriptional coregulation, transactivation or silencing may vary depending upon the biological context and the PIAS2 isoform studied. However, it seems to be mostly involved in gene silencing. Binds to sumoylated ELK1 and enhances its transcriptional activity by preventing recruitment of HDAC2 by ELK1, thus reversing SUMO-mediated repression of ELK1 transactivation activity. Isoform PIAS2-beta, but not isoform PIAS2-alpha, promotes MDM2 sumoylation. Isoform PIAS2-alpha promotes PARK7 sumoylation. Isoform PIAS2-beta promotes NCOA2 sumoylation more efficiently than isoform PIAS2- alpha. Isoform PIAS2-alpha sumoylates PML at'Lys-65' and 'Lys- 160'. {ECO:0000269|PubMed:15920481, ECO:0000269|PubMed:15976810, ECO:0000269|PubMed:22406621}.;
Pathway
Jak-STAT signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);JAK-STAT-Ncore;Androgen receptor signaling pathway;TGF-beta Signaling Pathway;sumoylation by ranbp2 regulates transcriptional repression;SUMOylation of DNA damage response and repair proteins;SUMOylation of transcription factors;IL12 signaling mediated by STAT4;SUMOylation of chromatin organization proteins;Post-translational protein modification;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation;Sumoylation by RanBP2 regulates transcriptional repression (Consensus)

Recessive Scores

pRec
0.287

Intolerance Scores

loftool
0.184
rvis_EVS
-0.43
rvis_percentile_EVS
25.37

Haploinsufficiency Scores

pHI
0.982
hipred
Y
hipred_score
0.748
ghis
0.578

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.993

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pias2
Phenotype
skeleton phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; vision/eye phenotype; reproductive system phenotype; pigmentation phenotype; cellular phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype;

Gene ontology

Biological process
protein sumoylation;androgen receptor signaling pathway;positive regulation of transcription, DNA-templated;negative regulation of androgen receptor signaling pathway
Cellular component
nucleus;nucleoplasm;PML body;nuclear speck
Molecular function
DNA binding;transcription coactivator activity;protein binding;transcription factor binding;zinc ion binding;SUMO transferase activity;ubiquitin protein ligase binding;androgen receptor binding;SUMO ligase activity